Companies: 10,795·Total market cap: $144.5T
Arch Therapeutics, Inc.

Arch Therapeutics, Inc.

ARTHOTCHealthcare
$0.00
+$0.00(+0.00%)
Market Cap$444
P/E Ratio
52W High$1.567
52W Low$0.0001

Arch Therapeutics, Inc.(ARTH)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · ARTH · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2023-092022-092021-092020-092019-09
Revenue
Revenue$0.08M$0.02M$0.01M$0.00M$0.00M
Cost of Revenue$0.08M$0.05M$0.03M$0.01M$0.01M
Gross Profit($0.00M)($0.04M)($0.01M)($0.01M)($0.01M)
Gross Margin %(computed)-3.22%-228.96%-127.25%
Operating Expenses
R&D Expenses$0.67M$1.15M$1.35M$1.61M$2.40M
G&A Expenses$4.37M$4.52M$5.01M$3.76M$3.97M
Total Operating Expenses$5.04M$5.67M$6.36M$5.37M$6.37M
Operating Income($5.04M)($5.71M)($6.38M)($5.37M)($6.37M)
Operating Margin %(computed)
Interest Income$0.00M$0.00M$0.00M$0.02M$0.00M
Interest Expense$3.10M$0.57M$0.15M$0.02M$0.00M
Income Before Tax($6.98M)($5.28M)($6.24M)($4.69M)($4.55M)
Income Tax Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Net Income($6.98M)($4.28M)($6.57M)($4.01M)($2.72M)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-2.27$-3.56$-5.97$-4.27$-3.27
Wtd Avg Shares3.07M1.20M1.10M0.94M0.83M
EBITDA($3.88M)($4.71M)($6.09M)($5.35M)($6.36M)
EBITDA Margin %(computed)

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解Arch Therapeutics, Inc.

关于Arch Therapeutics, Inc.(ARTH)损益表

Arch Therapeutics, Inc.(ARTH)损益表数据来源于SEC Form 10-K及10-Q申报文件。2023财年,ARTH实现营收$0.00B,毛利润($0.00B)(毛利率-3.22%),净利润($0.01B)(净利率-9221.43%)。

常见问题

ARTH · 4 问

Arch Therapeutics, Inc.(ARTH)2023财年营收为$0.00B,同比up383.8%。

ARTH revenueARTH salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09